ATE422049T1 - Festlegen von kritischen biologischen werten zur voraussage einer therapieresistenz - Google Patents

Festlegen von kritischen biologischen werten zur voraussage einer therapieresistenz

Info

Publication number
ATE422049T1
ATE422049T1 AT01980518T AT01980518T ATE422049T1 AT E422049 T1 ATE422049 T1 AT E422049T1 AT 01980518 T AT01980518 T AT 01980518T AT 01980518 T AT01980518 T AT 01980518T AT E422049 T1 ATE422049 T1 AT E422049T1
Authority
AT
Austria
Prior art keywords
therapy
therapy resistance
determining critical
critical biological
biological values
Prior art date
Application number
AT01980518T
Other languages
English (en)
Inventor
Kurt Hertogs
Brendan Larder
Richard P Harrigan
Original Assignee
Virco Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virco Bvba filed Critical Virco Bvba
Application granted granted Critical
Publication of ATE422049T1 publication Critical patent/ATE422049T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01980518T 2000-10-20 2001-10-22 Festlegen von kritischen biologischen werten zur voraussage einer therapieresistenz ATE422049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24183600P 2000-10-20 2000-10-20

Publications (1)

Publication Number Publication Date
ATE422049T1 true ATE422049T1 (de) 2009-02-15

Family

ID=22912373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980518T ATE422049T1 (de) 2000-10-20 2001-10-22 Festlegen von kritischen biologischen werten zur voraussage einer therapieresistenz

Country Status (9)

Country Link
US (1) US7292944B2 (de)
EP (1) EP1340075B1 (de)
JP (1) JP4264256B2 (de)
AT (1) ATE422049T1 (de)
AU (2) AU1234402A (de)
CA (1) CA2425772C (de)
DE (1) DE60137580D1 (de)
ES (1) ES2321809T3 (de)
WO (1) WO2002033402A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012270A (es) 1999-05-28 2003-06-24 Virco Nv Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
AU2002226316B2 (en) * 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
US6958211B2 (en) 2001-08-08 2005-10-25 Tibotech Bvba Methods of assessing HIV integrase inhibitor therapy
CA2490764C (en) 2002-07-01 2011-11-22 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1520036B1 (de) * 2002-07-01 2007-10-10 Tibotec Pharmaceuticals Ltd. Neue mutationsmuster in hiv-1 reverser transcriptase, die mit phenotypischer resistenz gegen medikamente korrelieren
EP1520247B1 (de) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutationsprofile bei mit phänotypischer medikamentenresistenz korrelierter hiv-1-protease
US20050214744A1 (en) * 2002-07-01 2005-09-29 Hilde Azjin New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
CA2557790A1 (en) 2004-03-02 2005-09-15 Virco Bvba Estimation of clinical cut-offs
WO2008090185A1 (en) 2007-01-23 2008-07-31 Virco Bvba Method for designing a drug regime for hiv-infected patients
US20080228700A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Attribute Combination Discovery
CA2688278A1 (en) 2007-05-25 2008-12-04 Tibotec Pharmaceuticals New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
US9336177B2 (en) * 2007-10-15 2016-05-10 23Andme, Inc. Genome sharing
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP2370929A4 (de) 2008-12-31 2016-11-23 23Andme Inc Suche nach verwandten in einer datenbank
CN109273023B (zh) * 2018-09-20 2022-05-17 科大讯飞股份有限公司 一种数据评测方法、装置、设备及可读存储介质
KR102261925B1 (ko) * 2018-12-05 2021-06-04 건국대학교 글로컬산학협력단 메타분석 및 생물경로 기반 기계 학습을 이용한 맞춤형 항암제 내성 예측 방법
US11461193B2 (en) * 2020-09-24 2022-10-04 International Business Machines Corporation Data storage volume recovery management

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226203B1 (en) * 1996-01-26 2008-06-30 Virco B V B A Method for determining of the chemotherapy of patients who are hiv positive based on the phenotypic drug sensitivity of human hiv strains
ES2175355T3 (es) 1996-01-29 2002-11-16 Virologic Inc Composiciones y metodos para determinar la susceptibilidad y la resistencia a farmacos antivirales y rastreo de farmacos antivirales.
US6103462A (en) * 1998-05-29 2000-08-15 Institut Pasteur Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
SE516103C2 (sv) 1998-07-08 2001-11-19 Ericsson Telefon Ab L M Förfarande och anordning i ett paketförmedlingsnät
MXPA01012270A (es) * 1999-05-28 2003-06-24 Virco Nv Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
US7138231B2 (en) * 2000-09-15 2006-11-21 Monogram Biosciences, Inc. Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
US20030190603A1 (en) * 2000-06-08 2003-10-09 Brendan Larder Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networks
US7324928B2 (en) * 2002-03-06 2008-01-29 Kitchen Scott G Method and system for determining phenotype from genotype

Also Published As

Publication number Publication date
CA2425772A1 (en) 2002-04-25
EP1340075B1 (de) 2009-01-28
EP1340075A2 (de) 2003-09-03
WO2002033402A2 (en) 2002-04-25
DE60137580D1 (de) 2009-03-19
JP2004511800A (ja) 2004-04-15
AU2002212344B2 (en) 2007-05-17
US20040033489A1 (en) 2004-02-19
US7292944B2 (en) 2007-11-06
JP4264256B2 (ja) 2009-05-13
WO2002033402A3 (en) 2002-06-13
AU1234402A (en) 2002-04-29
CA2425772C (en) 2012-07-24
ES2321809T3 (es) 2009-06-12

Similar Documents

Publication Publication Date Title
DE60137580D1 (de) Festlegen von kritischen biologischen werten zur voraussage einer therapieresistenz
CY1107733T1 (el) Μεθοδος για τον χαρακτηρισμο μιας βιολογικης καταστασης χρησιμοποιωντας βαθμοnομημενα προφιλ γονιδιακης εκφρασης
ATE412050T1 (de) Fluoreszenzprotein-sensoren zur erkennung von analyten
ATE227447T1 (de) Messeinrichtung zur ermittlung von physikalischen und/oder chemischen eigenschaften von gasen, flüssigkeiten und/oder feststoffen
DK1077634T3 (da) Monitorering af fysiologiske analytter
DE60216735D1 (de) Mikrokavitätsbiosensor, herstellungsverfahren und verwendungen davon
BR0306588A (pt) Biosensor possuindo eletrodo para determinar a taxa de fluxo de um fluido
DE69330067D1 (de) Analytische testvorrichtung einschliesslich negativ- und positivkontrolle
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
DE60024448D1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
DK1311707T3 (da) Massespektroskopisk analyse af biopolymerer
ATE239912T1 (de) Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen
WO2004044120A3 (en) Multiwell insert device that enables label free detection of cells and other objects
EP1478775A4 (de) Schneller und empfindlicher, auf abstand basierender assay zum nachweis und zur quantifizierung von dna-bindenden proteinen
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE226727T1 (de) Leistungssteigerung von bindungsassays mit verwendung mehr als einer markierungsmittel
ATE472732T1 (de) Testen von analyten mittels immunchromatographie mit lateraler migration
EP1409541A4 (de) Einzelliger biosensor zur messung von gpcr-liganden in einer zu untersuchenden probe
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE454418T1 (de) Chemische sensoren, die anilinpolysiloxane als empfindliche substanzen enthalten, und ihre verwendung zum nachweis und zur quantitativen analyse von nitroverbindungen
ATE259964T1 (de) Kompetitives assay-verfahren
DE602005008325D1 (de) Quantifizierung von Enzymaktivität mittels planarer Wellenleiter
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE248371T1 (de) Allergennachweis
Breuer et al. A biochemical/biophysical assay dyad for HTS-compatible triaging of inhibitors of the HIV-1 Nef/Hck SH3 interaction

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1340075

Country of ref document: EP